Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 1
2009 2
2010 1
2011 5
2012 8
2013 5
2014 1
2017 1
2018 1
2019 5
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Endocrinological evaluation of dawn phenomenon in patients with diabetes and comparison of insulin glargine U-100 biosimilar (Insulin Glargine BS Injection "Lilly") and glargine U-300 (Lantus XR): a randomized controlled study.
Hasebe M, Satoh S, Ito K, Tamura H, Terauchi Y. Hasebe M, et al. Among authors: tamura h. Endocr J. 2023 Aug 28;70(8):777-786. doi: 10.1507/endocrj.EJ22-0562. Epub 2023 May 11. Endocr J. 2023. PMID: 37164694 Free article. Clinical Trial.
Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study.
Suzuki J, Yamakawa T, Oba M, Nagakura J, Shigematsu E, Tamura H, Takahashi K, Okamoto Y, Sakamoto R, Shinoda M, Takano T, Kadonosono K, Terauchi Y. Suzuki J, et al. Among authors: tamura h. Endocr J. 2019 Nov 28;66(11):971-982. doi: 10.1507/endocrj.EJ18-0309. Epub 2019 Jul 4. Endocr J. 2019. PMID: 31270291 Free article. Clinical Trial.
33 results